Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FXI-ASO

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Genetically Determined FXI (Factor XI) Levels and Risk of Stroke
Background and Purpose— FXI (factor XI) is involved in thrombus propagation and stabilization. It is unknown whether lower FXI… Expand
  • figure 1
  • figure 2
Is this relevant?
2016
2016
In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.
INTRODUCTION Bleeding risk in factor XI (FXI) deficiency following surgery may be reduced by treatment with either of two FXI… Expand
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
BACKGROUND Experimental data indicate that reducing factor XI levels attenuates thrombosis without causing bleeding, but the role… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 2
Is this relevant?
2015
2015
Factor XI-related thrombosis and the role of concentrate treatment in factor XI deficiency.
The management of inherited factor XI (FXI) deficiency poses problems because of the poor relationship between the measured FXI… Expand
Is this relevant?
2015
2015
Anticoagulation therapy: Reducing factor XI with antisense oligonucleotides superior to endoxaparin for postoperative venous thromboembolism
Anticoagulation therapy: Reducing factor XI with antisense oligonucleotides superior to endoxaparin for postoperative venous… Expand
Is this relevant?
2015
2015
“GRIGORE T. POPA” UNIVERSITY OF MEDICINE AND PHARMACY, IASI FACULTY OF PHARMACY SUBJECT: PHAMACEUTICAL TECHNOLOGY AND BIOPHARMACY BUCCAL BIOADHESIVE PHARMACEUTICAL FORMULATIONS WITH MODIFIED RELEASE
  • 2015
    • Corpus ID: 51944595
 
  • figure IV
  • table V
  • table V
  • table V
  • figure VI
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
BACKGROUND: Patients undergoing total knee arthroplasty are at risk for postoperative venous thromboembolism (VTE). The… Expand
Is this relevant?
2014
2014
Co-Dependence of Extreme Events in High Frequency FX Returns
In this paper, we investigate extreme events in high frequency, multivariate FX returns within a purposely built framework. We… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.
The bleeding diathesis associated with hereditary factor XI (fXI) deficiency is prevalent in Ashkenazi Jews, in whom the disorder… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.
During normal hemostasis, the coagulation protease factor (F)XIa activates FIX. Hereditary deficiency of the FXIa precursor, FXI… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE